1 citations
,
January 2020 in “Skinmed” This review discusses the potential of exosome therapy for treating androgenetic alopecia but reports no new clinical results, highlighting the need for trials to confirm its efficacy and safety.
November 2025 in “Journal of Craniofacial Surgery Open” This study highlights exosome-based therapies as promising treatments for androgenetic alopecia, detailing protocol development, quality control measures, and clinical application examples, with mesenchymal stem cell-derived exosomes improving hair density in a case study without adverse effects.
July 2025 in “Russian Journal of Skin and Venereal Diseases” In this article, two patients with mild to moderate androgenetic alopecia showed improved hair density and reduced vellus hairs after treatment with exosome-derived solutions from salmon tissues, suggesting potential benefits of this approach.
August 2026 in “International Journal of Nanomedicine” This review highlights the potential of exosome-based therapies for androgenetic alopecia by modulating key signaling pathways in hair follicles, suggesting a promising treatment option that requires further research to validate long-term safety and efficacy.
This article provides a detailed analysis of exosome therapy as a novel treatment for hair loss, discussing its potential benefits, limitations, and the importance of standardized research reporting as human research remains limited.